Author

Velimir Luketic 1

1 McGuire DVAMC and Virginia Commonwealth University School of Medicine, Richmond, United States of America

DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 18 MONTHS OF OPEN-LABEL LONG-TERM SAFETY EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CIRRHOSIS

Michael Trauner, Frederik Nevens, Pietro Andreone, Giuseppe Mazzella, Simone Strasser, Christopher L. Bowlus, Pietro Invernizzi, Joost P.H. Drenth, Paul Pockros, Jaroslaw Regula, Annarosa Floreani, Simon Hohenester, Velimir Luketic, Mitchell Shiffman, Karel van Erpecum, Victor Vargas, Catherine Vincent, Bettina E. Hansen;;

DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 24 MONTHS OF OPEN-LABEL EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS

Michael Trauner, Frederik Nevens, Pietro Andreone, Giuseppe Mazzella, Simone Strasser, Pietro Invernizzi, Joost P.H. Drenth, Paul Pockros, Jaroslaw Regula, Annarosa Floreani, Simon Hohenester, Velimir Luketic, Mitchell Shiffman, Karel van Erpecum, Victor Vargas, Catherine Vincent, Bettina E. Hansen, Christopher L. Bowlus;;

EFFICACY OF OBETICHOLIC ACID IN THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS BY CONTINENTAL REGIONS

Velimir Luketic, Pietro Andreone, Frederik Nevens, Janet Owens-Grillo, Richard Pencek, Tonya Marmon, Leigh MacConell

SAFETY OF ABT-450/R/OMBITASVIR + DASABUVIR WITH OR WITHOUT RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS: RESULTS FROM PEARL II, PEARL III, AND PEARL IV

Richard Aspinall, Jacob Lalezari, Yan Luo, Ronald Pruitt, Velimir Luketic, Giovanni Gaeta, Iwona Olszok, William King, Selim Gürel, Yiran Hu, Jeffrey Enejosa, Daniel E. Cohen, Nancy Shulman

Item 1 - 4 / 4
1